Package 70518-2518-1

{"route": ["ORAL"], "spl_id": "4a652104-b1e5-e0fb-e063-6394a90a8f00", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197313"], "spl_set_id": ["736679be-469e-4bdb-8e15-b10751c3dd60"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BLISTER PACK (70518-2518-1)", "package_ndc": "70518-2518-1", "marketing_start_date": "20200706"}, {"sample": false, "description": "10 TABLET in 1 BOTTLE, PLASTIC (70518-2518-2)", "package_ndc": "70518-2518-2", "marketing_start_date": "20230412"}], "brand_name": "Acyclovir", "product_id": "70518-2518_4a652104-b1e5-e0fb-e063-6394a90a8f00", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "70518-2518", "generic_name": "Acyclovir", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "800 mg/1"}], "application_number": "ANDA203834", "marketing_category": "ANDA", "marketing_start_date": "20200101", "listing_expiration_date": "20271231"}